γδ T cells are increased in the peripheral blood of patients with gastric cancer

Clinica Chimica Acta

Volumn 413, Issue 19-20, 2012, Pages 1495-1499

  Lee, A Jin ^a   Kim, Sang Gyung ^a   Chae, Hyun Dong ^a   Lee, Geon Ho ^a   Shin, Im Hee ^a  

^a Daegu University   (South Korea)

Author keywords

Gamma delta T cells; Gastric cancer; Lymphocyte subset; Tumor immunology

Indexed keywords

CD16 ANTIGEN; CD19 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD56 ANTIGEN; CD8 ANTIGEN;

ADULT; AGED; ARTICLE; CANCER STAGING; CD3+ T LYMPHOCYTE; CD4 CD8 RATIO; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; GAMMA DELTA T LYMPHOCYTE; GAMMA DELTA T LYMPHOCYTE PERCENTAGE; HUMAN; HUMAN CELL; LYMPH NODE METASTASIS; LYMPHOCYTE COUNT; LYMPHOCYTE FUNCTION; LYMPHOCYTE SUBPOPULATION; MALE; PRIORITY JOURNAL; STOMACH CANCER; TUMOR IMMUNITY;

ADULT; AGED; BIOLOGICAL MARKERS; CD4-CD8 RATIO; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOPHENOTYPING; LYMPHOCYTE SUBSETS; MALE; MIDDLE AGED; NEOPLASM GRADING; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; STOMACH NEOPLASMS;

EID: 84863109471     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2012.06.016     Document Type: Article

References (28)

1. Ziegler H.K. The role of gamma/delta T cells in immunity to infection and regulation of inflammation. Immunol Res 2004, 29:293-302.
2. Lauritsen J.P., Haks M.C., Lefebvre J.M., et al. Recent insights into the signals that control alphabeta/gammadelta-lineage fate. Immunol Rev 2006, 209:176-190.
3. Pellegrin J.L., Taupin J.L., Dupon M., et al. Gammadelta T cells increase with Mycobacterium avium complex infection but not with tuberculosis in AIDS patients. Int Immunol 1999, 11:1475-1478.
4. Morita C.T., Jin C., Sarikonda G., et al. Nonpeptide antigens, presentation mechanisms, and immunological memory of human Vgamma2Vdelta2 T cells: discriminating friend from foe through the recognition of prenyl pyrophosphate antigens. Immunol Rev 2007, 215:59-76.
5. Ferrarini M., Ferrero E., Dagna L., et al. Human gammadelta T cells: a nonredundant system in the immune-surveillance against cancer. Trends Immunol 2002, 23:14-18.
6. Hayday A., Tigelaar R. Immunoregulation in the tissues by gammadelta T cells. Nat Rev Immunol 2003, 3:233-242.
7. Carding S.R., Egan P.J. Gammadelta T cells: functional plasticity and heterogeneity. Nat Rev Immunol 2002, 2:336-345.
8. Balbi B., Valle M.T., Oddera S., et al. T-lymphocytes with gamma delta+ V delta 2+ antigen receptors are present in increased proportions in a fraction of patients with tuberculosis or with sarcoidosis. Am Rev Respir Dis 1993, 148:1685-1690.
9. Mathiot N.D., Krueger R., French M.A., et al. Percentage of CD3+CD4-CD8-gammadeltaTCR- T cells is increased by HIV disease. AIDS Res Hum Retroviruses 2001, 17:977-980.
10. Bas M., Bier H., Schirlau K., et al. Gamma-delta T-cells in patients with squamous cell carcinoma of the head and neck. Oral Oncol 2006, 42:691-697.
11. Kobayashi H., Tanaka Y., Yagi J., et al. Gamma/delta T cells provide innate immunity against renal cell carcinoma. Cancer Immunol Immunother 2001, 50:115-124.
12. Gaafar A., Aljurf M.D., Al-Sulaiman A., et al. Defective gammadelta T-cell function and granzyme B gene polymorphism in a cohort of newly diagnosed breast cancer patients. Exp Hematol 2009, 37:838-848.
13. Meraviglia S., Eberl M., Vermijlen D., et al. In vivo manipulation of Vgamma9Vdelta2 T cells with zoledronate and low-dose interleukin-2 for immunotherapy of advanced breast cancer patients. Clin Exp Immunol 2010, 161:290-297.
14. Nakajima J., Murakawa T., Fukami T., et al. A phase I study of adoptive immunotherapy for recurrent non-small-cell lung cancer patients with autologous gammadelta T cells. Eur J Cardiothorac Surg 2010, 37:1191-1197.
15. Bennouna J., Bompas E., Neidhardt E.M., et al. Phase-I study of Innacell gammadelta, an autologous cell-therapy product highly enriched in gamma9delta2 T lymphocytes, in combination with IL-2, in patients with metastatic renal cell carcinoma. Cancer Immunol Immunother 2008, 57:1599-1609.
16. Parkin D.M., Bray F., Ferlay J., et al. Global cancer statistics, 2002. CA Cancer J Clin 2005, 55:74-108.
17. Franciosi C., Bravo A.F., Romano F., et al. Immunodeficiency in radically operable gastric cancer patients. Hepatogastroenterology 2002, 49:857-859.
18. Hong W.S., Min Y.I., Son Y.S., et al. Peripheral blood lymphocyte subsets I patients with stomach cancer. J Korean Med Sci 1995, 10:164-168.
19. Milasiene V., Stratilatovas E., Norkiene V. The importance of T-lymphocyte subsets on overall survival of colorectal and gastric cancer patients. Medicina (Kaunas) 2007, 43:548-554.
20. Whiteside T.L. Immune responses to malignancies. J Allergy Clin Immunol 2010, 125:S272-S283.
21. Davey M.S., Lin C.Y., Roberts G.W., et al. Human neutrophil clearance of bacterial pathogens triggers anti-microbial gammadelta T cell responses in early infection. PLoS Pathog 2011, 7:e1002040.
22. Kuroda H., Saito H., Ikeguchi M. Decreased number and reduced NKG2D expression of Vdelta1 gammadelta T cells are involved in the impaired function of Vdelta1 gammadelta T cells in the tissue of gastric cancer. Gastric Cancer 2012, 18. [S10120-011-0138-x].
23. Kobayashi H., Tanaka Y., Nakazawa H., et al. A new indicator of favorable prognosis in locally advanced renal cell carcinomas: gamma delta T-cells in peripheral blood. Anticancer Res 2011, 31:1027-1031.
24. Meza-Junco J., Au H.J., Sawyer M.B. Critical appraisal of trastuzumab in treatment of advanced stomach cancer. Cancer Manage Res 2011, 3:57-64.
25. Riethmuller G., Johnson J.P. Monoclonal antibodies in the detection and therapy of micrometastatic epithelial cancers. Curr Opin Immunol 1992, 4:647-655.
26. Petrie H.T., Scollay R., Shortman K. Commitment to the T cell receptor-alpha beta or -gamma delta lineages can occur just prior to the onset of CD4 and CD8 expression among immature thymocytes. Eur J Immunol 1992, 22:2185-2188.
27. Dillman R.O., Koziol J.A., Zavanelli M.I., et al. Immunoincompetence in cancer patients. Assessment by in vitro stimulation tests and quantification of lymphocyte subpopulations. Cancer 1984, 53:1484-1491.
28. Satomi A., Murakami S., Ishida K., et al. Significance of increased neutrophils in patients with advanced colorectal cancer. Acta Oncol 1995, 34:69-73.